The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health (NIH), has begun studies on three continents that could have broad implications for HIV prevention research. Enrollment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV infection. Known as the […]

Go to Original Post